The growth in the historic period can be attributed to rising prevalence of type 2 diabetes, increased awareness of glycemic control therapies, strong clinical efficacy versus traditional antidiabetics, physician preference for incretin-based therapies, favorable reimbursement in developed markets
Animal studies have shown potential risks to fetal development, and there is insufficient data on their safety in human pregnancy
RFM plus liraglutide, a GLP1 receptor agonist commonly prescribed for obesity and diabetes
doi:10.1038/s41591-024-02970-5 PubMed: This substudy demonstrated that retatrutide reduced liver fat by 81-82% at the 8mg and 12mg doses over 24 weeks, providing evidence of retatrutides multi-system metabolic benefits beyond weight loss
If you are hungry between meals, that is fine
A clinician will recommend the best option for you based on your health profile, goals, and how you respond to treatment